<b>Conclusions</b>: PN's prospects as a host-directed, antiviral treatment for COVID-19 are demonstrated by its coordinated modulation of the PI3K/AKT, JAK-STAT, SRC-family kinase, EGFR, and SYK pathways. The gene discussed is AKT1; the disease is COVID-19.